• Explore /
  • Poster
  • / Evaluation of trastuzumab without chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients: Randomized controlled trial (RESPECT).

Evaluation of trastuzumab without chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients: Randomized controlled trial (RESPECT).

Abstract Poster

Authors

null

Masataka Sawaki

Aichi Cancer Center Hospital, Nagoya, Japan

Masataka Sawaki , Tsuyoshi Saito , Shinichi Baba , Kokoro Kobayashi , Hiroaki Kawashima , Michiko Tsuneizumi , Noriko Sagawa , Hiroko Bando , Masato Takahashi , Miki Yamaguchi , Tsutomu Takashima , Takahiro Nakayama , Masahiro Kashiwaba , Toshiro Mizuno , Yutaka Yamamoto , Naruto Taira , Hiroji Iwata , Yukari Uemura , Yasuo Ohashi , Hirofumi Mukai

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT01104935

Citation

J Clin Oncol 36, 2018 (suppl; abstr 510)

DOI

10.1200/JCO.2018.36.15_suppl.510

Abstract #

510

Poster Bd #

2

Abstract Disclosures

Similar Posters

First Author: Sherko Kummel

First Author: P. Ravdin

First Author: Giacomo Pelizzari

First Author: Thomas Aparicio